Project measures / variables set:   Graham1   CD4_spleen

ID, description, units MPD:63333   CD4_spleen   percentage of CD3+ T cells that are CD4+ in spleen, post infection   [%]  
West Nile virus study
Measures • day 7    • day 12    • day 21    • day 28
Data set, strains Graham1   CC RIX   2 strains     sex: m     age: 8-10wks
Procedure immune cell quantification
Comparisontimecourse but different cohorts
Ontology mappings

  SIDE-BY-SIDE STRAIN CURVES
Values
Graph Type
Dimensions Width:  ×  Height: px
Plot Options


  OVERLAPPING STRAIN CURVES
Data
Dimensions px
Toggle Series   
Plot Options

Graham1 - percentage of CD3+ T cells that are CD4+ in spleen, post infection





  ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary     

Factor DF Sum of squares Mean sum of squares F value p-value (Pr>F)
group 3 337.3283 112.4428 1.0948 0.3799
strain 1 1187.2267 1187.2267 11.5592 0.0037
group:strain 3 553.99 184.6633 1.7979 0.1881
Residuals 16 1643.3333 102.7083

Q-Q normality assessment based on residuals

  


  INDIVIDUAL MEASURES
ProjectIDTreatmentMeasure / Variable Description PanelStrains
tested
SexAge
Graham1 63333 immune cell quantification West Nile virus percentage of CD3+ T cells that are CD4+ in spleen, post infection   [%]   day 7  CD4_spleen_d7 CC RIX 2 m 8-10wks
Graham1 63334 immune cell quantification West Nile virus percentage of CD3+ T cells that are CD4+ in spleen, post infection   [%]   day 12  CD4_spleen_d12 CC RIX 2 m 8-10wks
Graham1 63335 immune cell quantification West Nile virus percentage of CD3+ T cells that are CD4+ in spleen, post infection   [%]   day 21  CD4_spleen_d21 CC RIX 2 m 8-10wks
Graham1 63336 immune cell quantification West Nile virus percentage of CD3+ T cells that are CD4+ in spleen, post infection   [%]   day 28  CD4_spleen_d28 CC RIX 2 m 8-10wks